Woman who had pioneering cancer treatment 18 years ago still in remissionA woman has remained cancer-free for over 18 years following CAR T-cell therapy for neuroblastoma, showing promise for solid tumor treatments.
Revolutionary CAR-T cell therapy looks to break through beyond blood cancerCAR-T cell therapy revolutionizes blood cancer treatment by enhancing T-lymphocytes to combat tumors, with potential for wider application beyond hematological cancers.
Woman who had pioneering cancer treatment 18 years ago still in remissionA woman has remained cancer-free for over 18 years following CAR T-cell therapy for neuroblastoma, showing promise for solid tumor treatments.
Revolutionary CAR-T cell therapy looks to break through beyond blood cancerCAR-T cell therapy revolutionizes blood cancer treatment by enhancing T-lymphocytes to combat tumors, with potential for wider application beyond hematological cancers.
Targeting Protein Interactions May Boost Antitumor Immunity in Breast Cancer - News CenterTargeting OTUD4-CD73 axis boosts immune response in immune-suppressive breast cancers.